Voglibose & Metformin Tablets Generics - Manufacturers & Suppliers
Voglimet, Voglinorm-M, Volibo-M, Vogli-Met(India/Japan)
| Product/Composition:- | Voglibose & Metformin Tablets |
|---|---|
| Strength:- | (Voglibose 0.2/0.3 mg) + (Metformin 500/850 mg) |
| Form:- | Tablets |
| Reference Brands:- | Voglimet, Voglinorm-M, Volibo-M, Vogli-Met(India/Japan) |
| MOQ | As per the manufacturer batch size |
| Get Quote Send Enquiry on WhatsApp | |
Metformin reduces hepatic glucose production and increases insulin sensitivity, while Voglibose delays carbohydrate absorption in the intestine by inhibiting α-glucosidase. Together, they effectively control fasting and postprandial blood glucose. This synergistic action improves glycemic control in Type 2 Diabetes, especially in patients with high post-meal glucose spikes.
Voglibose + Metformin combination tablets (0.2/0.3 mg Voglibose with 500/850 mg Metformin) are not approved by the FDA (USA) or EMA (EU) for marketing. Voglibose lacks regulatory approval in both regions due to limited clinical data per Western standards. However, this fixed-dose combination is widely approved and marketed in India, Japan, and other parts of Asia for managing Type 2 Diabetes Mellitus, particularly for postprandial hyperglycemia. Brands like Voglimet, Voglinorm-M, and Volibo-M are common. For sourcing, global B2B buyers can access compliant manufacturers through platforms like Pharmatradz.com.